Cargando…

Endothelial progenitor cell number is not decreased in 34 children with Juvenile Dermatomyositis: a pilot study

OBJECTIVE: A pilot study to determine endothelial progenitor cells (EPC) number in children with Juvenile Dermatomyositis (JDM). METHODS: After obtaining informed consent, the EPC number from 34 fasting children with definite/probable JDM at various stages of therapy—initially untreated, active dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Dong, Kacha-Ochana, Akadia, Morgan, Gabrielle A., Huang, Chiang-Ching, Pachman, Lauren M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436461/ https://www.ncbi.nlm.nih.gov/pubmed/28514969 http://dx.doi.org/10.1186/s12969-017-0171-3

Ejemplares similares

Serum protein biomarkers for juvenile dermatomyositis: a pilot study
por: Tawalbeh, Shefa M., et al.
Publicado: (2020)

Clues to Disease Activity in Juvenile Dermatomyositis: Neopterin and Other Biomarkers
por: Khojah, Amer, et al.
Publicado: (2021)

Lower NK cell numbers in children with untreated juvenile dermatomyositis during the COVID-19 pandemic
por: Costin, Christopher, et al.
Publicado: (2023)

B Cell Lymphocytosis in Juvenile Dermatomyositis
por: Costin, Christopher, et al.
Publicado: (2023)

The von Willebrand Factor Antigen Reflects the Juvenile Dermatomyositis Disease Activity Score
por: Gibbs, Ellie, et al.
Publicado: (2023)

Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity
por: Pachman, Lauren M., et al.
Publicado: (2023)

Juvenile Dermatomyositis: Association between Nail Fold Capillary End Row Loops Area Under the Curve and Disease Damage Indicators
por: Khojah, Amer, et al.
Publicado: (2023)

Juvenile dermatomyositis: association between nail fold capillary end row loop– area under the curve– and disease damage indicators
por: Khojah, Amer, et al.
Publicado: (2023)

Changes in total body fat and body mass index among children with juvenile dermatomyositis treated with high-dose glucocorticoids
por: Khojah, Amer, et al.
Publicado: (2021)

Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy
por: Pachman, Lauren M., et al.
Publicado: (2021)

Increased Otoferlin Expression in B Cells Is Associated with Muscle Weakness in Untreated Juvenile Dermatomyositis: A Pilot Study
por: Bukhari, Ameera, et al.
Publicado: (2023)

Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis
por: Duvvuri, Bhargavi, et al.
Publicado: (2023)

Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive
por: Roberson, Elisha D. O., et al.
Publicado: (2022)

Coding joint: kappa-deleting recombination excision circle ratio and B cell activating factor level: predicting juvenile dermatomyositis rituximab response, a proof-of-concept study
por: Ochfeld, Elisa, et al.
Publicado: (2022)

Characteristics of Adults Aged ≥18 Years Evaluated for Substance Use and Treatment Planning — United States, 2019
por: Kacha-Ochana, Akadia, et al.
Publicado: (2022)

Monitoring change in volume of calcifications in juvenile idiopathic inflammatory myopathy: a pilot study using low dose computed tomography
por: Ibarra, Maria, et al.
Publicado: (2016)

Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis
por: Chen, Yi-Wen, et al.
Publicado: (2008)

Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis
por: Conklin, Laurie S., et al.
Publicado: (2018)

Juvenile Dermatomyositis
por: Rhim, Jung Woo
Publicado: (2022)

Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis
por: Wienke, Judith, et al.
Publicado: (2020)

Characterizing and Identifying the Prevalence of Web-Based Misinformation Relating to Medication for Opioid Use Disorder: Machine Learning Approach
por: ElSherief, Mai, et al.
Publicado: (2021)

Juvenile Dermatomyositis in Pregnancy
por: Madu, Anthony Emeka, et al.
Publicado: (2013)

The Vasculopathy of Juvenile Dermatomyositis
por: Papadopoulou, Charalampia, et al.
Publicado: (2018)

The Number of Endothelial Progenitor Cells is Decreased in Patients With Non-Dipper Hypertension
por: Kim, Seunghwan, et al.
Publicado: (2012)

Gastroparesis associated with Juvenile Dermatomyositis
por: Martin, N, et al.
Publicado: (2008)

Respiratory involvement in juvenile dermatomyositis
por: Fabi, M, et al.
Publicado: (2008)

Juvenile dermatomyositis in Western Switzerland
por: Enders, F Bellutti, et al.
Publicado: (2011)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Calcinosis Universalis in Juvenile Dermatomyositis
por: Chung, Chong Hyuk
Publicado: (2020)

Juvenile Dermatomyositis—Clinical Phenotypes
por: Li, Danyang, et al.
Publicado: (2019)

The Significance of Autoantibodies in Juvenile Dermatomyositis
por: Kwiatkowska, Dominika, et al.
Publicado: (2021)

Clinically Amyopathic Juvenile Dermatomyositis
por: Yıldırım, Deniz Gezgin, et al.
Publicado: (2023)

Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research
por: McCann, Liza J, et al.
Publicado: (2018)

Pregnancy-Induced Hypertension is Accompanied by Decreased Number of Circulating Endothelial Cells and Circulating Endothelial Progenitor Cells
por: Heimrath, Jerzy, et al.
Publicado: (2014)

Treatment of refractory juvenile dermatomyositis with tacrolimus
por: Hassan, J, et al.
Publicado: (2008)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008)

Dyslipidemia in active juvenile dermatomyositis patients
por: Kozu, KT, et al.
Publicado: (2011)

Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011)

Subclinical pulmonary abnormalities in juvenile dermatomyositis
por: Sallum, Adriana M, et al.
Publicado: (2014)

Juvenile dermatomyositis without skin lesions
por: Nilipour, Yalda, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v04mtkjvucpahumnnocinttp0m